Ginkgo Bioworks Holdings (DNA) EPS (Diluted) (QoQ) (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) EPS (Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ginkgo Bioworks Holdings | 432.60 Mn | 348.06 Mn | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 262.55% |
| Mar 31, 2026 | 91.92% |
| Dec 31, 2025 | -0.31% |
| Sep 30, 2025 | -32.06% |
| Jun 30, 2025 | -679.67% |
| Mar 31, 2025 | 93.20% |
| Dec 31, 2024 | -91.94% |
| Sep 30, 2024 | 74.46% |
| Jun 30, 2024 | -27.74% |
| Mar 31, 2024 | 24.01% |
| Dec 31, 2023 | 29.88% |
| Sep 30, 2023 | -73.21% |
| Jun 30, 2023 | 99.92% |
| Mar 31, 2023 | -103,694.27% |
| Dec 31, 2022 | 74.92% |
| Sep 30, 2022 | 0.69% |
| Jun 30, 2022 | 99.89% |
| Mar 31, 2022 | -31,035.20% |
| Dec 31, 2021 | -1,424.90% |
| Sep 30, 2021 | -83.61% |